DA-001 (Applied Biology)
- Generic Name
- DA-001 (Applied Biology)
Clinical Study of DA-001 As a Treatment for Telogen Effluvium
Phase 3
Not yet recruiting
- Conditions
- Telogen Effluvium
- Interventions
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Applied Biology, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06648850
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath